385 related articles for article (PubMed ID: 34525338)
1. Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutières-syndrome-like encephalopathy.
Nakahama T; Kato Y; Shibuya T; Inoue M; Kim JI; Vongpipatana T; Todo H; Xing Y; Kawahara Y
Immunity; 2021 Sep; 54(9):1976-1988.e7. PubMed ID: 34525338
[TBL] [Abstract][Full Text] [Related]
2. Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses.
Tang Q; Rigby RE; Young GR; Hvidt AK; Davis T; Tan TK; Bridgeman A; Townsend AR; Kassiotis G; Rehwinkel J
Immunity; 2021 Sep; 54(9):1961-1975.e5. PubMed ID: 34525337
[TBL] [Abstract][Full Text] [Related]
3. The RNA-editing enzyme ADAR1: a regulatory hub that tunes multiple dsRNA-sensing pathways.
Nakahama T; Kawahara Y
Int Immunol; 2023 Mar; 35(3):123-133. PubMed ID: 36469491
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the Biological Significance of ADAR1-Z-RNA Interactions.
Nakahama T; Kawahara Y
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768866
[TBL] [Abstract][Full Text] [Related]
5. ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation.
de Reuver R; Dierick E; Wiernicki B; Staes K; Seys L; De Meester E; Muyldermans T; Botzki A; Lambrecht BN; Van Nieuwerburgh F; Vandenabeele P; Maelfait J
Cell Rep; 2021 Aug; 36(6):109500. PubMed ID: 34380029
[TBL] [Abstract][Full Text] [Related]
6. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.
Guo X; Wiley CA; Steinman RA; Sheng Y; Ji B; Wang J; Zhang L; Wang T; Zenatai M; Billiar TR; Wang Q
J Neuroinflammation; 2021 Jul; 18(1):169. PubMed ID: 34332594
[TBL] [Abstract][Full Text] [Related]
7. Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown.
Chung H; Calis JJA; Wu X; Sun T; Yu Y; Sarbanes SL; Dao Thi VL; Shilvock AR; Hoffmann HH; Rosenberg BR; Rice CM
Cell; 2018 Feb; 172(4):811-824.e14. PubMed ID: 29395325
[TBL] [Abstract][Full Text] [Related]
8. RNA editing at a limited number of sites is sufficient to prevent MDA5 activation in the mouse brain.
Kim JI; Nakahama T; Yamasaki R; Costa Cruz PH; Vongpipatana T; Inoue M; Kanou N; Xing Y; Todo H; Shibuya T; Kato Y; Kawahara Y
PLoS Genet; 2021 May; 17(5):e1009516. PubMed ID: 33983932
[TBL] [Abstract][Full Text] [Related]
9. An Aicardi-Goutières Syndrome-Causative Point Mutation in
Inoue M; Nakahama T; Yamasaki R; Shibuya T; Kim JI; Todo H; Xing Y; Kato Y; Morii E; Kawahara Y
J Immunol; 2021 Dec; 207(12):3016-3027. PubMed ID: 34772697
[TBL] [Abstract][Full Text] [Related]
10. Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.
Rice GI; Kasher PR; Forte GM; Mannion NM; Greenwood SM; Szynkiewicz M; Dickerson JE; Bhaskar SS; Zampini M; Briggs TA; Jenkinson EM; Bacino CA; Battini R; Bertini E; Brogan PA; Brueton LA; Carpanelli M; De Laet C; de Lonlay P; del Toro M; Desguerre I; Fazzi E; Garcia-Cazorla A; Heiberg A; Kawaguchi M; Kumar R; Lin JP; Lourenco CM; Male AM; Marques W; Mignot C; Olivieri I; Orcesi S; Prabhakar P; Rasmussen M; Robinson RA; Rozenberg F; Schmidt JL; Steindl K; Tan TY; van der Merwe WG; Vanderver A; Vassallo G; Wakeling EL; Wassmer E; Whittaker E; Livingston JH; Lebon P; Suzuki T; McLaughlin PJ; Keegan LP; O'Connell MA; Lovell SC; Crow YJ
Nat Genet; 2012 Nov; 44(11):1243-8. PubMed ID: 23001123
[TBL] [Abstract][Full Text] [Related]
11. The RNA-editing enzyme ADAR1 controls innate immune responses to RNA.
Mannion NM; Greenwood SM; Young R; Cox S; Brindle J; Read D; Nellåker C; Vesely C; Ponting CP; McLaughlin PJ; Jantsch MF; Dorin J; Adams IR; Scadden AD; Ohman M; Keegan LP; O'Connell MA
Cell Rep; 2014 Nov; 9(4):1482-94. PubMed ID: 25456137
[TBL] [Abstract][Full Text] [Related]
12. ADAR1 Zα domain P195A mutation activates the MDA5-dependent RNA-sensing signaling pathway in brain without decreasing overall RNA editing.
Guo X; Liu S; Sheng Y; Zenati M; Billiar T; Herbert A; Wang Q
Cell Rep; 2023 Jul; 42(7):112733. PubMed ID: 37421629
[TBL] [Abstract][Full Text] [Related]
13. ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation.
de Reuver R; Verdonck S; Dierick E; Nemegeer J; Hessmann E; Ahmad S; Jans M; Blancke G; Van Nieuwerburgh F; Botzki A; Vereecke L; van Loo G; Declercq W; Hur S; Vandenabeele P; Maelfait J
Nature; 2022 Jul; 607(7920):784-789. PubMed ID: 35859175
[TBL] [Abstract][Full Text] [Related]
14. The role of RNA editing enzyme ADAR1 in human disease.
Song B; Shiromoto Y; Minakuchi M; Nishikura K
Wiley Interdiscip Rev RNA; 2022 Jan; 13(1):e1665. PubMed ID: 34105255
[TBL] [Abstract][Full Text] [Related]
15. ADAR1 entraps sinister cellular dsRNAs, thresholding antiviral responses.
Keegan LP; Vukić D; O'Connell MA
Trends Immunol; 2021 Nov; 42(11):953-955. PubMed ID: 34642093
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase R and the integrated stress response drive immunopathology caused by mutations in the RNA deaminase ADAR1.
Maurano M; Snyder JM; Connelly C; Henao-Mejia J; Sidrauski C; Stetson DB
Immunity; 2021 Sep; 54(9):1948-1960.e5. PubMed ID: 34343497
[TBL] [Abstract][Full Text] [Related]
17. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself.
Liddicoat BJ; Piskol R; Chalk AM; Ramaswami G; Higuchi M; Hartner JC; Li JB; Seeburg PH; Walkley CR
Science; 2015 Sep; 349(6252):1115-20. PubMed ID: 26275108
[TBL] [Abstract][Full Text] [Related]
18. The ADAR1 editome reveals drivers of editing-specificity for ADAR1-isoforms.
Kleinova R; Rajendra V; Leuchtenberger AF; Lo Giudice C; Vesely C; Kapoor U; Tanzer A; Derdak S; Picardi E; Jantsch MF
Nucleic Acids Res; 2023 May; 51(9):4191-4207. PubMed ID: 37026479
[TBL] [Abstract][Full Text] [Related]
19. Decoupling expression and editing preferences of ADAR1 p150 and p110 isoforms.
Sun T; Yu Y; Wu X; Acevedo A; Luo JD; Wang J; Schneider WM; Hurwitz B; Rosenberg BR; Chung H; Rice CM
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33723056
[TBL] [Abstract][Full Text] [Related]
20. ADAR1 averts fatal type I interferon induction by ZBP1.
Jiao H; Wachsmuth L; Wolf S; Lohmann J; Nagata M; Kaya GG; Oikonomou N; Kondylis V; Rogg M; Diebold M; Tröder SE; Zevnik B; Prinz M; Schell C; Young GR; Kassiotis G; Pasparakis M
Nature; 2022 Jul; 607(7920):776-783. PubMed ID: 35859176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
